1. Home
  2. PAHC vs STAA Comparison

PAHC vs STAA Comparison

Compare PAHC & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • STAA
  • Stock Information
  • Founded
  • PAHC 1946
  • STAA 1982
  • Country
  • PAHC United States
  • STAA United States
  • Employees
  • PAHC N/A
  • STAA N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • STAA Ophthalmic Goods
  • Sector
  • PAHC Health Care
  • STAA Health Care
  • Exchange
  • PAHC Nasdaq
  • STAA Nasdaq
  • Market Cap
  • PAHC 968.3M
  • STAA 850.9M
  • IPO Year
  • PAHC 2014
  • STAA N/A
  • Fundamental
  • Price
  • PAHC $29.49
  • STAA $17.29
  • Analyst Decision
  • PAHC Hold
  • STAA Hold
  • Analyst Count
  • PAHC 4
  • STAA 7
  • Target Price
  • PAHC $24.50
  • STAA $18.20
  • AVG Volume (30 Days)
  • PAHC 341.9K
  • STAA 704.0K
  • Earning Date
  • PAHC 08-27-2025
  • STAA 08-06-2025
  • Dividend Yield
  • PAHC 1.63%
  • STAA N/A
  • EPS Growth
  • PAHC 140.17
  • STAA N/A
  • EPS
  • PAHC 0.78
  • STAA N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • STAA $279,134,000.00
  • Revenue This Year
  • PAHC $28.13
  • STAA N/A
  • Revenue Next Year
  • PAHC $13.11
  • STAA $27.83
  • P/E Ratio
  • PAHC $37.79
  • STAA N/A
  • Revenue Growth
  • PAHC 19.12
  • STAA N/A
  • 52 Week Low
  • PAHC $16.16
  • STAA $13.50
  • 52 Week High
  • PAHC $31.80
  • STAA $44.48
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 64.77
  • STAA 53.00
  • Support Level
  • PAHC $29.64
  • STAA $16.80
  • Resistance Level
  • PAHC $31.71
  • STAA $18.00
  • Average True Range (ATR)
  • PAHC 1.07
  • STAA 0.66
  • MACD
  • PAHC -0.01
  • STAA 0.07
  • Stochastic Oscillator
  • PAHC 69.12
  • STAA 73.29

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: